Physician profile
Michael Patrick Murphy
NPI 1013964410
$2,186.92
in general payments reported to CMS, 2019-2025
10 companies · $308 in 2025
The $308 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $947 · 2021: $144 · 2022: $16.57 · 2023: $185 · 2024: $586 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614 · Travel and Lodging: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.58 |
| Travel and Lodging | $464.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $947.42 | 2020 | |
| Medtronic, INC. | $780.14 | 2021-2024 | Ellipsys Vascular Access System, Sinuva |
| Integra Lifesciences Corporation | $168.40 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Smith+Nephew, INC. | $117.68 | 2025 | Halo |
| Alk-Abello, INC | $57.11 | 2021-2023 | Grastek, Odactra |
| Itamar Medical INC | $36.86 | 2021 | |
| Intersect Ent, INC. | $25.32 | 2021 | |
| Glaxosmithkline, LLC. | $21.54 | 2025 | Nucala |
| Philips North America LLC | $16.34 | 2023 | |
| Optinose US, INC. | $16.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.